Franklin Resources Inc. Has $2.67 Million Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Franklin Resources Inc. lifted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 14.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 37,637 shares of the company’s stock after purchasing an additional 4,621 shares during the quarter. Franklin Resources Inc.’s holdings in Henry Schein were worth $2,673,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Tidal Investments LLC grew its stake in Henry Schein by 54.9% in the third quarter. Tidal Investments LLC now owns 13,942 shares of the company’s stock valued at $1,016,000 after acquiring an additional 4,939 shares during the period. Wilmington Savings Fund Society FSB bought a new position in shares of Henry Schein during the 3rd quarter valued at about $109,000. Virtu Financial LLC acquired a new position in shares of Henry Schein in the 3rd quarter valued at approximately $239,000. TCW Group Inc. increased its stake in Henry Schein by 6.6% during the 3rd quarter. TCW Group Inc. now owns 26,368 shares of the company’s stock worth $1,922,000 after purchasing an additional 1,628 shares in the last quarter. Finally, Toronto Dominion Bank raised its holdings in Henry Schein by 68.3% during the 3rd quarter. Toronto Dominion Bank now owns 62,779 shares of the company’s stock worth $4,577,000 after buying an additional 25,474 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Insider Buying and Selling

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.14% of the stock is currently owned by corporate insiders.

Henry Schein Stock Down 0.1 %

NASDAQ:HSIC opened at $70.01 on Thursday. The firm has a market capitalization of $8.73 billion, a price-to-earnings ratio of 28.81, a price-to-earnings-growth ratio of 2.31 and a beta of 0.87. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The stock’s 50 day moving average price is $72.35 and its two-hundred day moving average price is $70.15.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same period in the prior year, the firm posted $1.32 earnings per share. The company’s quarterly revenue was up .4% compared to the same quarter last year. Equities research analysts expect that Henry Schein, Inc. will post 4.78 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Mizuho started coverage on Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price for the company. Evercore ISI lifted their price target on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a research report on Wednesday, November 6th. Seven research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $78.89.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.